Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
---|
05/02/2007 | EP1778705A1 Phosphonium ionic liquids as recyclable solvents for solution phase chemistry |
05/02/2007 | EP1778704A1 Process for the preparation of asymmetrically substituted biaryldiphosphines |
05/02/2007 | EP1778703A1 Coupling agents comprising a photolabile protecting group and uses thereof, such as for the functionalisation of solid supports |
05/02/2007 | EP1778702A2 Antiviral compounds |
05/02/2007 | EP1778699A2 Targeting chelants and chelates |
05/02/2007 | EP1778252A2 Noncardiotoxic pharmaceutical compounds |
05/02/2007 | EP1778250A2 Novel thiazole inhibitors of fructose 1,6-bisphosphatase |
05/02/2007 | EP1778249A2 Nucleoside phosphonate conjugates as anti hiv agents |
05/02/2007 | EP1480979B1 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates |
05/02/2007 | EP1299342B1 Method for producing 3,3-diarylpropylamines |
05/02/2007 | CN1957115A Method for electroplating bath chemistry control |
05/02/2007 | CN1957001A Alkoxyamines containing a radically polymerizable group |
05/02/2007 | CN1956780A Affinity particle and affinity separation method |
05/02/2007 | CN1956779A Affinity particle and affinity separation method |
05/02/2007 | CN1956723A Sulfonylethyl phosphorodiamidates |
05/02/2007 | CN1955185A Optical active substitution oxyphosphonate salt acetate and its use |
05/02/2007 | CN1955176A Optical separation method substituting oxyphosphonate acetate |
05/02/2007 | CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
05/01/2007 | US7211705 Vinylaromatic copolymers in which the first styrene monomer is substituted with catalytically active functional groups and the second styrene monomer is substituted with lipophilic groups; polyisobutylene bound to a catalytically active group |
05/01/2007 | US7211690 One-step process for making phosphonium haloalkylsulfonate antistatic agent by combining an alkyl sulfonate salt of lithium or Sodium with a tetraalkylphosphonium halogen in an aqueous medium; simple mixing of the reactants results in a precipitation of the anti-static molecule in high yield |
05/01/2007 | US7211663 Antiinflammatory agents; immobilized on solid support |
05/01/2007 | CA2282515C Process for the carbonylation of ethylene |
05/01/2007 | CA2268434C Mycophenolic bisphosphonate derivatives and their preparation from tetraphosphonate bicyclic trisanhydrides |
05/01/2007 | CA2155493C Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives |
05/01/2007 | CA2146203C Enhancement of the storage stability of organic phosphites and phosphonites |
05/01/2007 | CA2132131C 3-arylbenzofuranones as stabilisers |
04/26/2007 | WO2007047315A1 Amifostine dihydrate crystalline composition |
04/26/2007 | WO2007046729A1 Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose |
04/26/2007 | WO2007045496A1 Novel urokinase inhibitors |
04/26/2007 | US20070093454 sodium channel modulators, such as Isobutyl 4-(6-(2-hydroxyphenyl)pyrimidin-4-yl)piperazine-1-carboxylate, used as analgesics |
04/26/2007 | DE102004063360B4 Bisphenyl-2,3,5,6-tetrafluor-4-trifluormethylphenylphosphinoxid-Derivat und dessen Synthese Bisphenyl-2,3,5,6-tetrafluoro-4-trifluormethylphenylphosphinoxid derivative and its synthesis |
04/25/2007 | EP1777297A1 Fluorescent substrates for detecting organophosphatase enzyme activity |
04/25/2007 | EP1478652B1 Components for producing amphoteric liposomes |
04/25/2007 | EP1438132B1 Phosphonites used in catalyst systems for the addition of prussic acid to olefinic double bonds and for the isomerisation of organic nitriles |
04/25/2007 | EP1305037B1 Analgesic medicament |
04/25/2007 | CN1954079A Process for producing phospholipid containing long chain polyunsaturated fatty acid as constituent thereof and utilization of the same |
04/25/2007 | CN1953986A Purification of N-(phosphonomethyl)glycine |
04/25/2007 | CN1953985A Prodrugs of piperazine and substituted piperidine antiviral agents |
04/25/2007 | CN1953953A Metal complex comprising beta-diketonato as ligand |
04/25/2007 | CN1951946A Chiral monodentate phosphite ligands, its preparation method and uses |
04/25/2007 | CN1951945A Phosphine-phosphoramidite ligand, its preparation method and uses |
04/25/2007 | CN1951944A Dedevap continuous production method |
04/25/2007 | CN1951903A Process for preparing 2-cyclohexenone compounds |
04/25/2007 | CN1312163C Hydroxy ethylidene diphosphonic acid with content of greater than or equal to 90 percent and process for making same |
04/25/2007 | CN1312162C Organic phosphine compound with both hole and electron channel structure and its oxide and prepn process |
04/25/2007 | CN1312161C 3-hydroxy-4,3',4',5'-tetromethoxy bibenzyl phosphate and its composition, prepn and application |
04/25/2007 | CN1312135C Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents |
04/24/2007 | US7208633 Process for preparation of diphosphine compounds and intermediates for the process |
04/24/2007 | US7208626 Reacting a (perfluoroalkyl)phosphorane fluoride with a hydride ion donor such as triethylsilane, tripropylsilane or sodium borohydride while refluxing |
04/24/2007 | US7208623 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
04/24/2007 | US7208606 Using carbon monoxide and hydrogen in presence of phosphine-containing cobalt hydroformylation catalyst |
04/24/2007 | US7208605 Functionalized ionic liquids, and methods of use thereof |
04/24/2007 | US7208557 Functional monomers for molecular recognition and catalysis |
04/24/2007 | US7208551 Ultraviolet radiation transparency and reflectance; satellites |
04/24/2007 | US7208527 Potassium channel modulators |
04/24/2007 | US7208489 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
04/24/2007 | US7208481 Monitoring the protein concentration in plasma or tissues; treating atherosclerosis, Alzheimer's disease, macular degeneration, retinitis pigmentosa, stroke, degenerative neuropathy, multiple sclerosis, xanthoma, xanthelasma, cardiovascular disorder; tetramethyl N-(2-pyridyl)aminomethylenediphosphonate |
04/24/2007 | US7208471 Glycopeptide phosphonate derivatives |
04/24/2007 | US7208452 Process for manufacturing alkylphosphonate monoesters |
04/24/2007 | US7208427 Precursor compositions and processes for MOCVD of barrier materials in semiconductor manufacturing |
04/24/2007 | CA2337872C Cross-linked phenoxyphosphazene compound, process for producing the same, flame retardant, flame-retardant resin composition, and molded flame-retardant resin |
04/24/2007 | CA2289472C Excitatory amino acid receptor modulators |
04/24/2007 | CA2271892C Synthesis of ruthenium or osmium metathesis catalysts |
04/24/2007 | CA2230517C Novel phosphino derivatives |
04/24/2007 | CA2159776C Imidobisphosphoric acids, process for their preparation, and use thereof |
04/19/2007 | WO2007044489A1 Flame retardant composition and method |
04/19/2007 | WO2007044204A2 Propylene copolymer compositions |
04/19/2007 | WO2007043450A1 Perfluoropolyether compound and lubricant and magnetic disk each containing or employing the same |
04/19/2007 | WO2007043202A1 Stable novel nitron compound and use thereof |
04/19/2007 | WO2007042431A1 Stabilization of polyolefins with liquid cyclic phosphites |
04/19/2007 | WO2007042048A2 Method for preparing crystalline sodium risedronate |
04/19/2007 | US20070088176 one-step, low cost, simple reaction with anhydrous hydrogen fluoride (HF), and converte into the corresponding phosphoranes by treatment with electrophilic reagents or Lewis acids; ionic liquid tributylethylphosphonium hexafluoroantimonate complexes with SbF5 |
04/19/2007 | US20070088166 Phosphine Ligand (L1c)(4-Di-tert-butylphosphanyl-1,5-diphenyl-1H-[1,2,3]triazole; forms complexes with transition metal; useful catalysts in coupling reactions such as Suzuki-Miyaura coupling, Stille coupling, Negishi coupling, Sonagashira coupling and hydrogenation |
04/19/2007 | US20070088161 Novel chelated bisphosphonates for use as pharmaceutical agents |
04/19/2007 | US20070088004 MAO-B inhibitors useful for treating obesity |
04/19/2007 | US20070088002 Orally available sphingosine 1-phosphate receptor agonists and antagonists |
04/19/2007 | US20070087446 Aromatic phosphonium salts and their use as labeling reagents in mass spectrometry analysis |
04/19/2007 | DE102006013724B3 Polymer mass, useful to prepare molded article, films, fibers or shaped parts, comprises a polymer e.g. polyolefin and additive from phosphorus oxy compound |
04/19/2007 | CA2625376A1 Stabilization of polyolefins with liquid cyclic phosphites |
04/18/2007 | EP1775302A1 Method for preparing crystalline sodium risedronate |
04/18/2007 | EP1775301A1 Novel supported phosphazene catalysts, novel compounds for the catalysts, and use thereof |
04/18/2007 | EP1774331A2 Cytoxan antibodies and immunoassay |
04/18/2007 | EP1773935A1 Phosphorus-containing flame retardant for thermoplastic polymers |
04/18/2007 | EP1773853A1 Monophosphine compounds, transition metal complexes thereof and production of optically active compounds using the complexes as asymmetric catalysts |
04/18/2007 | EP1773852A1 Method for producing phosphate silanes |
04/18/2007 | EP1773851A2 Improved method for making phosphoric acid |
04/18/2007 | EP1773850A2 Prodrugs of hiv protease inhibitors |
04/18/2007 | EP1773751A1 Process for preparing solid particles of phenolic antioxidants |
04/18/2007 | EP1773750A1 Chemical compounds |
04/18/2007 | EP1773740A1 Neurologically-active compounds |
04/18/2007 | EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
04/18/2007 | EP1773352A2 Improved process for the preparation of oxidized phospholipids |
04/18/2007 | EP1628778B1 Strongly adherent surface coatings |
04/18/2007 | EP1425276B1 Heterocyclic carboxamides and their use as fungicides |
04/18/2007 | EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors |
04/18/2007 | EP1345918B1 1,5 benzothiazepines and their use as antihyperlipidemics |
04/18/2007 | CN1951156A Organic electroluminescent element and manufacturing method thereof, organic compound containing phosphorous and manufacturing method thereof |
04/18/2007 | CN1950436A Flame retardants |
04/18/2007 | CN1950383A Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases |
04/18/2007 | CN1950344A Pharmaceutical compositions |